glutamic acid has been researched along with Dementia in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (20.59) | 18.7374 |
| 1990's | 7 (20.59) | 18.2507 |
| 2000's | 10 (29.41) | 29.6817 |
| 2010's | 8 (23.53) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Aljabali, AAA; Chellappan, DK; Dua, K; Goyal, R; Sarena, P; Sharma, A; Taliyan, R; Tambuwala, MM; Urmera, MT | 1 |
| Bansod, P; Swathi, KP; Tripathi, AS | 1 |
| D'Adamio, L; Tambini, MD; Yao, W; Yin, T | 1 |
| Kashimoto, Y; Kitano, Y; Makino, M; Murasawa, H; Pawlak, A; Takahashi-Ito, K | 1 |
| Abner, E; Caban-Holt, A; Davis, R; Gold, BT; Head, E; Jicha, G; Lin, AL; Powell, D; Robertson, W; Schmitt, FA; Wilcock, DM | 1 |
| Ikarashi, Y; Mizoguchi, K | 1 |
| Bae, K; Ban, JY; Cho, SO; Jeong, HY; Kim, JY; Lee, IS; Seong, YH; Song, KS | 1 |
| Iizuka, S; Ikarashi, Y; Imamura, S; Kanno, H; Kase, Y; Kawakami, Z; Sekiguchi, K; Takeda, S; Yamaguchi, T; Yuzurihara, M | 1 |
| Francis, PT | 1 |
| Howland, RH | 1 |
| Batassini, C; Bernardi, C; Biasibetti, R; Costa, AP; Gonçalves, CA; Leal, RB; Lopes, MW; Tortorelli, LS; Tramontina, AC; Wartchow, KM | 1 |
| Götz, J; Ittner, LM; Nilsen, LH; Rae, C; Sonnewald, U | 1 |
| Aschner, M; Sidoryk-Wegrzynowicz, M | 1 |
| Addae, JI; Youssef, FF | 1 |
| Addae, JI; Stone, TW; Youssef, FF | 1 |
| Becker, H; Blin, O; Micallef, J; Tardieu, S | 1 |
| BARDONI, F; DEL GRECO, V | 1 |
| Richartz, E; Schott, KJ; Wormstall, H | 1 |
| Annesi, F; Annesi, G; Arabia, G; Caracciolo, M; Cirò Candiano, IC; Civitelli, D; D'Amelio, M; Fierro, B; La Bella, V; Piccoli, F; Piccoli, T; Pugliese, P; Quattrone, A; Ragonese, P; Savettieri, G; Tarantino, P | 1 |
| Francis, PT; Perry, EK | 1 |
| Achaval, M; Biasibetti, R; de Almeida, LM; de Oliveira, LF; Gonçalves, CA; Gottfried, C; Leite, MC; Quillfeldt, JA; Rodrigues, L; Swarowsky, A | 1 |
| Bowen, DM; Davison, AN; Neary, D; Sims, NR; Smith, CC | 1 |
| Coyle, JT; McKinney, M; Price, D; Singer, H | 1 |
| Dewhurst, S; Fine, SM; Gelbard, HA | 1 |
| Asai, S; Hata, H; Ishikawa, K; Kubo, T; Matsumoto, A; Shibanoki, S | 1 |
| Chang, L; Ernst, T; Mehringer, CM; Melchor, R | 1 |
| Kornbuber, J; Kornhuber, J; Wiltfang, J | 1 |
| Canevari, L; Dagani, F; Di Paolo, E; Ferrari, R; Tosca, P; Verzé, S; Zerbi, F | 1 |
| Kitamura, Y; Nomura, Y | 1 |
| Heathfield, KW; Pearson, SJ; Reynolds, GP | 1 |
| Chang, LJ; Hornykiewicz, O; Kish, SJ; Mirchandani, L; Shannak, K | 1 |
| Bowen, DM; Francis, PT; Neary, D; Smith, CC; Snowden, JS | 1 |
| Davison, AN | 1 |
| Connick, JH; English, M; Hastings, MH; Stone, TW; Winn, P | 1 |
14 review(s) available for glutamic acid and Dementia
| Article | Year |
|---|---|
Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients.
Topics: Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Catecholamines; Dementia; Drugs, Chinese Herbal; Endoplasmic Reticulum; gamma-Aminobutyric Acid; Glutamic Acid; Glycyrrhetinic Acid; Humans; Indole Alkaloids; Inflammation; Medicine, Kampo; Rats; Receptors, Serotonin; Uncaria | 2016 |
Altered glutamate neurotransmission and behaviour in dementia: evidence from studies of memantine.
Topics: Dementia; Excitatory Amino Acid Antagonists; Glutamic Acid; Glycogen Synthase Kinase 3; Humans; Memantine; Neurofibrillary Tangles; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; tau Proteins | 2009 |
Manganese toxicity in the central nervous system: the glutamine/glutamate-γ-aminobutyric acid cycle.
Topics: Central Nervous System; Dementia; Evidence-Based Medicine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Manganese; Parkinson Disease | 2013 |
Learning may provide neuroprotection against dementia.
Topics: Alzheimer Disease; Animals; Dementia; Educational Status; Glutamic Acid; Humans; Learning; Long-Term Potentiation; Memory; Risk Factors | 2002 |
Neuroprotective role of learning in dementia: a biological explanation.
Topics: Amyloid beta-Protein Precursor; Calcium; Cognition; Dementia; Epidemiologic Studies; Glutamic Acid; Homeostasis; Humans; Learning; Long-Term Potentiation; Receptors, Glutamate | 2003 |
[Treatment of non-dopamine-dependent signs in parkinsonian syndromes: evaluation and results].
Topics: Anti-Dyskinesia Agents; Botulinum Toxins; Cholinesterase Inhibitors; Clozapine; Dementia; Depressive Disorder; Dopamine; Glutamic Acid; Humans; Movement Disorders; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Treatment Outcome | 2003 |
[Psychotropic drug treatment in dementia disorders].
Topics: Aged; Aged, 80 and over; Aging; Antidepressive Agents; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glutamic Acid; Humans; Male; Memantine; Psychotropic Drugs; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2004 |
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies.
Topics: Acetylcholine; Atrophy; Cerebral Cortex; Cholinergic Fibers; Dementia; Glutamic Acid; Humans; Lewy Body Disease; Nerve Degeneration; Parkinson Disease; Receptors, Nicotinic; Serotonin; Synaptic Transmission | 2007 |
Neurotransmitter specific alterations in dementing disorders: insights from animal models.
Topics: Alzheimer Disease; Animals; Brain; Cats; Cerebral Cortex; Cholinergic Fibers; Dementia; Disease Models, Animal; Dopamine; G(M1) Ganglioside; gamma-Aminobutyric Acid; Gangliosidoses; Glutamates; Glutamic Acid; Humans; Neurotransmitter Agents; Norepinephrine; Rats; Serotonin; Synaptic Transmission | 1984 |
Neuropathogenesis of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Dementia; Forecasting; Glutamic Acid; HIV-1; Humans; Neurotoxins; Oxidative Stress | 1996 |
Hippocampal degeneration inducing impairment of learning in rats: model of dementia?
Topics: Animals; Dementia; Glutamic Acid; Hippocampus; Learning Disabilities; Nerve Degeneration; Rats; Trimethyltin Compounds | 1997 |
The role of glutamate in dementia.
Topics: Animals; Dementia; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate | 1998 |
The ageing brain and dementia--a review.
Topics: Alzheimer Disease; Cerebral Cortex; Choline O-Acetyltransferase; Cholinergic Fibers; Dementia; Glutamates; Glutamic Acid; Humans; Neurotransmitter Agents | 1985 |
Endogenous excitotoxic agents.
Topics: Animals; Aspartic Acid; Cell Survival; Central Nervous System; Dementia; Epilepsy; Glutamates; Glutamic Acid; Humans; Huntington Disease; Models, Neurological; Neurons; Quinolinic Acid; Quinolinic Acids | 1987 |
20 other study(ies) available for glutamic acid and Dementia
| Article | Year |
|---|---|
Chronic Light-Distorted Glutamate-Cortisol Signaling, Behavioral and Histological Markers, and Induced Oxidative Stress and Dementia: An Amelioration by Melatonin.
Topics: Animals; Biomarkers; Circadian Rhythm; Dementia; Dextromethorphan; Glutamic Acid; Hydrocortisone; Light; Melatonin; Mifepristone; N-Methylaspartate; Oxidative Stress; Rats; Rats, Wistar | 2022 |
Activation of 5-HT 1b/d receptor restores the cognitive function by reducing glutamate release, deposition of β-amyloid and TLR-4 pathway in the brain of scopolamine-induced dementia in rat.
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Models, Animal; Glutamic Acid; Glutathione; Glutathione Peroxidase; Maze Learning; Memory Disorders; Oxazolidinones; Oxidative Stress; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Scopolamine; Serotonin; Serotonin 5-HT1 Receptor Agonists; Superoxide Dismutase; Toll-Like Receptor 4; Tryptamines | 2021 |
The Familial dementia gene ITM2b/BRI2 facilitates glutamate transmission via both presynaptic and postsynaptic mechanisms.
Topics: Adaptor Proteins, Signal Transducing; Animals; Dementia; Disease Models, Animal; Glutamic Acid; Hippocampus; Humans; Long-Term Potentiation; Mice; Mice, Knockout; Mutation; Neurons; Presynaptic Terminals; RNA, Messenger; Synaptic Potentials | 2019 |
Memantine ameliorates learning and memory disturbance and the behavioral and psychological symptoms of dementia in thiamine-deficient mice.
Topics: Administration, Oral; Animals; Anxiety; Behavior, Animal; Biogenic Monoamines; Body Weight; Dementia; Depression; Disease Models, Animal; Glutamic Acid; Hippocampus; Locomotion; Male; Maze Learning; Memantine; Memory; Mice; Thiamine Deficiency | 2019 |
(1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.
Topics: Activities of Daily Living; Adult; Analysis of Variance; Aspartic Acid; Dementia; Down Syndrome; Female; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Inositol; Male; Middle Aged; Neuropsychological Tests; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2016 |
Aralia cordata protects against amyloid beta protein (25-35)-induced neurotoxicity in cultured neurons and has antidementia activities in mice.
Topics: Amyloid beta-Peptides; Animals; Aralia; Calcium; Cell Death; Cells, Cultured; Cerebral Cortex; Cholinesterases; Dementia; Drugs, Chinese Herbal; Female; Glutamic Acid; Hippocampus; Male; Memory Disorders; Mice; Mice, Inbred ICR; Neurons; Oleanolic Acid; Pregnancy; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2009 |
Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats.
Topics: Aggression; Animals; Anxiety; Astrocytes; Behavior, Animal; Brain; Dementia; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Fungi; Glutamic Acid; Magnoliopsida; Male; Medicine, East Asian Traditional; Medicine, Kampo; Memory Disorders; Neurons; Phytotherapy; Rats; Rats, Wistar; Social Behavior; Thiamine Deficiency | 2009 |
Drug therapies for cognitive impairment and dementia.
Topics: Aged; Caprylates; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Food, Formulated; Ginkgo biloba; Glutamic Acid; Humans; Nootropic Agents; Phytotherapy; Plant Extracts; Receptors, N-Methyl-D-Aspartate; Triglycerides | 2010 |
Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia.
Topics: Animals; Cognition Disorders; Dementia; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Glial Fibrillary Acidic Protein; Glutamate-Ammonia Ligase; Glutamic Acid; Glutathione; Hippocampus; Humans; Male; Microinjections; Mitogen-Activated Protein Kinases; Nerve Growth Factors; Neuroglia; Okadaic Acid; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; S100 Proteins | 2012 |
Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation.
Topics: Acetates; Animals; Astrocytes; Cerebellar Cortex; Dementia; Female; gamma-Aminobutyric Acid; Glucose; Glutamic Acid; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Mutation; Neurons; Neurotransmitter Agents; Phosphorylation; tau Proteins; Transgenes | 2013 |
[Several cases of alcoholic and amential psychoses treated with a glutamic acid derivative].
Topics: Dementia; Glutamates; Glutamic Acid; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders | 1959 |
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.
Topics: Amyotrophic Lateral Sclerosis; Blotting, Northern; Dementia; DNA Mutational Analysis; Exons; Family Health; Female; Glutamic Acid; Humans; Intracellular Signaling Peptides and Proteins; Male; Mucoproteins; Mutation; Oncogene Proteins; Parkinsonian Disorders; Protein Deglycase DJ-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2005 |
Glial alterations in the hippocampus of rats submitted to ibotenic-induced lesion of the nucleus basalis magnocellularis.
Topics: Animals; Astrocytes; Avoidance Learning; Basal Nucleus of Meynert; Brain Damage, Chronic; Cell Count; Cholinergic Fibers; Dementia; Disease Models, Animal; Exploratory Behavior; Follow-Up Studies; Glial Fibrillary Acidic Protein; Glutamate-Ammonia Ligase; Glutamic Acid; Habituation, Psychophysiologic; Hippocampus; Ibotenic Acid; Immunohistochemistry; Male; Nerve Growth Factors; Rats; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Statistics, Nonparametric; Time Factors | 2008 |
Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Amino Acids; Aspartic Acid; Dementia; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Potassium; Temporal Lobe | 1983 |
Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Dementia; Discriminant Analysis; Female; Frontal Lobe; Glutamic Acid; Glutamine; Humans; Hydrogen; Inositol; Lactates; Linear Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Neuroglia; Neurons; Parietal Lobe; Protons; Sensitivity and Specificity; Temporal Lobe | 1997 |
Glutamate and GABA levels in CSF from patients affected by dementia and olivo-ponto-cerebellar atrophy.
Topics: Age Factors; Aged; Aged, 80 and over; Dementia; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Luminescent Measurements; Male; Middle Aged; Neuropsychological Tests; Olivopontocerebellar Atrophies; Parkinson Disease | 1992 |
[Transsynaptic and transmembrane control and aging--cellular and molecular aspect].
Topics: Acetylcholine; Aging; Animals; Dementia; Disease Models, Animal; Dopamine; Glutamates; Glutamic Acid; Mice; Norepinephrine; Signal Transduction; Synapses; Synaptic Transmission | 1991 |
Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex.
Topics: Adult; Aged; Caudate Nucleus; Cerebral Cortex; Choline O-Acetyltransferase; Dementia; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Huntington Disease; Male; Middle Aged; Neurotransmitter Agents | 1990 |
Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Brain; Bulbar Palsy, Progressive; Choline O-Acetyltransferase; Dementia; Dopamine; Female; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Neurons; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Serotonin | 1985 |
Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Topics: Adult; Aged; Alzheimer Disease; Amino Acids; Aspartic Acid; Dementia; Epilepsy; Female; Glutamates; Glutamic Acid; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents | 1985 |